ABT-333 074 Smiles: OC(=O)CCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O

Smiles: OC(=O)CCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O

Characterization of Sugar Contents and Sucrose Metabolizing Enzymes in Developing Leaves of Hevea brasiliensis

and dose-dependently suppresses VEGF-induced survival and migration of endothelial cells in the same dose range without cytotoxic or antiproliferative effect on cells that do not express VEGF receptors

FH535 represses pancreatic cancer xenograft growth and angiogenesis

(−)-Sphingosine

ABT-333 074 Smiles: OC(=O)CCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=ODasabuvir, also known as ABT 333, is a non nucleoside polymerase inhibitor currently under clinical trials for the treatment of Hepatitis C. In the United States, it is approved by the Food and Drug Administration for use in combination with ombitasvir, paritaprevir, and ritonavir in the product Viekira Pak. Dasabuvir acts as a NS5B (an RNA directed RNA polymerase) inhibitor. Product information CAS Number: 1132935 63 7 Molecular Weight: 493. 57